Selected Cell
Cell:
Value:
Pcitri.ignored_ids.dumb.final.p
Sheet3
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
16001
16002
16003
16004
16005
16006
16007
16008
16009
16010
16011
16012
16013
16014
16015
16016
16017
16018
16019
16020
16021
16022
16023
16024
16025
16026
16027
16028
16029
16030
16031
16032
16033
16034
16035
16036
16037
16038
16039
16040
16041
16042
16043
16044
16045
16046
16047
16048
16049
16050
16051
16052
16053
16054
16055
16056
16057
16058
16059
16060
16061
16062
16063
16064
16065
16066
16067
16068
16069
16070
16071
16072
16073
16074
16075
16076
16077
16078
16079
16080
16081
16082
16083
16084
16085
16086
16087
16088
16089
16090
16091
16092
16093
16094
16095
16096
16097
16098
16099
16100
16101
16102
16103
16104
16105
16106
16107
16108
16109
16110
16111
16112
16113
16114
16115
16116
16117
16118
16119
16120
16121
16122
16123
16124
16125
16126
16127
16128
16129
16130
16131
16132
16133
16134
16135
16136
16137
16138
16139
16140
16141
16142
16143
16144
16145
16146
16147
16148
16149
16150
16151
16152
16153
16154
16155
16156
16157
16158
16159
16160
16161
16162
16163
16164
16165
16166
16167
16168
16169
16170
16171
16172
16173
16174
16175
16176
16177
16178
16179
16180
16181
16182
16183
16184
16185
16186
16187
16188
16189
16190
16191
16192
16193
16194
16195
16196
16197
16198
16199
16200
| UnnamedSample_HQ_transcript/1965|m.1042 | UnnamedSample_HQ_transcript/1965 | Coverage 0.335 too low. | 5e0021a45f24b52c0d68b338ae8003eb | 1546 | Pfam | PF01839 | FG-GAP repeat | 409 | 452 | 2.0E-6 | T | 22-09-2020 | IPR013517 | FG-GAP repeat |
| UnnamedSample_HQ_transcript/1965|m.1042 | UnnamedSample_HQ_transcript/1965 | Coverage 0.335 too low. | 5e0021a45f24b52c0d68b338ae8003eb | 1546 | Pfam | PF01839 | FG-GAP repeat | 331 | 371 | 3.1E-10 | T | 22-09-2020 | IPR013517 | FG-GAP repeat |
| UnnamedSample_HQ_transcript/1965|m.1042 | UnnamedSample_HQ_transcript/1965 | Coverage 0.335 too low. | 5e0021a45f24b52c0d68b338ae8003eb | 1546 | Pfam | PF08441 | Integrin alpha | 518 | 959 | 1.4E-74 | T | 22-09-2020 | IPR013649 | Integrin alpha-2 |
| UnnamedSample_HQ_transcript/26499|m.8605 | UnnamedSample_HQ_transcript/26499 | Coverage 0.740 too low. | ddb669a5c57491871db523cf1a2da48c | 414 | Pfam | PF01476 | LysM domain | 219 | 261 | 2.5E-9 | T | 22-09-2020 | IPR018392 | LysM domain |
| UnnamedSample_HQ_transcript/83363|m.20247 | UnnamedSample_HQ_transcript/83363 | Identity 0.713 too low. | 2ea334f21cd0fd625ea4fa18a1339956 | 111 | Pfam | PF00089 | Trypsin | 2 | 90 | 5.4E-6 | T | 22-09-2020 | IPR001254 | Serine proteases, trypsin domain |
| UnnamedSample_HQ_transcript/104421|m.23157 | UnnamedSample_HQ_transcript/104421 | Coverage 0.893 too low. | 2ea334f21cd0fd625ea4fa18a1339956 | 111 | Pfam | PF00089 | Trypsin | 2 | 90 | 5.4E-6 | T | 22-09-2020 | IPR001254 | Serine proteases, trypsin domain |
| UnnamedSample_HQ_transcript/2891|m.1401 | UnnamedSample_HQ_transcript/2891 | Coverage 0.917 too low. | e0279aad369d0e919d24ba6d6fe298b2 | 560 | Pfam | PF01429 | Methyl-CpG binding domain | 469 | 531 | 4.0E-8 | T | 22-09-2020 | IPR001739 | Methyl-CpG DNA binding |
| UnnamedSample_HQ_transcript/5565|m.2376 | UnnamedSample_HQ_transcript/5565 | Identity 0.867 too low. | 27d54ef0062219bc99bfd0e2a26f4060 | 1427 | Pfam | PF00176 | SNF2 family N-terminal domain | 516 | 783 | 2.3E-62 | T | 22-09-2020 | IPR000330 | SNF2-related, N-terminal domain |
| UnnamedSample_HQ_transcript/5565|m.2376 | UnnamedSample_HQ_transcript/5565 | Identity 0.867 too low. | 27d54ef0062219bc99bfd0e2a26f4060 | 1427 | Pfam | PF18375 | CDH1/2 SANT-Helical linker 1 | 1152 | 1245 | 6.0E-37 | T | 22-09-2020 | IPR040793 | CDH1/2, SANT-Helical linker 1 |
| UnnamedSample_HQ_transcript/5565|m.2376 | UnnamedSample_HQ_transcript/5565 | Identity 0.867 too low. | 27d54ef0062219bc99bfd0e2a26f4060 | 1427 | Pfam | PF00385 | Chromo (CHRromatin Organisation MOdifier) domain | 411 | 461 | 7.4E-15 | T | 22-09-2020 | IPR023780 | Chromo domain |
| UnnamedSample_HQ_transcript/5565|m.2376 | UnnamedSample_HQ_transcript/5565 | Identity 0.867 too low. | 27d54ef0062219bc99bfd0e2a26f4060 | 1427 | Pfam | PF00385 | Chromo (CHRromatin Organisation MOdifier) domain | 294 | 366 | 4.4E-9 | T | 22-09-2020 | IPR023780 | Chromo domain |
| UnnamedSample_HQ_transcript/5565|m.2376 | UnnamedSample_HQ_transcript/5565 | Identity 0.867 too low. | 27d54ef0062219bc99bfd0e2a26f4060 | 1427 | Pfam | PF00271 | Helicase conserved C-terminal domain | 810 | 922 | 1.1E-19 | T | 22-09-2020 | IPR001650 | Helicase, C-terminal |
| UnnamedSample_HQ_transcript/114228|m.24314 | UnnamedSample_HQ_transcript/114228 | Coverage 0.989 too low. | fa3832253e618f008de37243e7128ffa | 185 | Pfam | PF00201 | UDP-glucoronosyl and UDP-glucosyl transferase | 1 | 163 | 4.4E-61 | T | 22-09-2020 | IPR002213 | UDP-glucuronosyl/UDP-glucosyltransferase |
| UnnamedSample_HQ_transcript/50806|m.14204 | UnnamedSample_HQ_transcript/50806 | Coverage 0.985 too low. | a280e63a6c000aac58c2567242f6a5d3 | 511 | Pfam | PF00651 | BTB/POZ domain | 1 | 69 | 6.4E-11 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/50806|m.14204 | UnnamedSample_HQ_transcript/50806 | Coverage 0.985 too low. | a280e63a6c000aac58c2567242f6a5d3 | 511 | Pfam | PF07707 | BTB And C-terminal Kelch | 83 | 163 | 1.0E-4 | T | 22-09-2020 | IPR011705 | BTB/Kelch-associated |
| UnnamedSample_HQ_transcript/82904|m.20178 | UnnamedSample_HQ_transcript/82904 | Coverage 0.593 too low. | ab08cb80edd83274127baa34f1e688d1 | 413 | Pfam | PF00079 | Serpin (serine protease inhibitor) | 30 | 410 | 1.6E-85 | T | 22-09-2020 | IPR023796 | Serpin domain |
| UnnamedSample_HQ_transcript/67002|m.17413 | UnnamedSample_HQ_transcript/67002 | Identity 0.497 too low. | ab08cb80edd83274127baa34f1e688d1 | 413 | Pfam | PF00079 | Serpin (serine protease inhibitor) | 30 | 410 | 1.6E-85 | T | 22-09-2020 | IPR023796 | Serpin domain |
| UnnamedSample_HQ_transcript/28778|m.9161 | UnnamedSample_HQ_transcript/28778 | Coverage 0.738 too low. | f9155ffff972cf4f2fd0478fa256e2ef | 614 | Pfam | PF19056 | WD40 repeated domain | 253 | 468 | 1.4E-49 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/108045|m.23584 | UnnamedSample_HQ_transcript/108045 | Coverage 0.164 too low. | 0a2ede3a15b9c49a8ee0cd221aa8b83f | 109 | Pfam | PF13716 | Divergent CRAL/TRIO domain | 1 | 92 | 4.8E-23 | T | 22-09-2020 | IPR001251 | CRAL-TRIO lipid binding domain |
| UnnamedSample_HQ_transcript/7376|m.2977 | UnnamedSample_HQ_transcript/7376 | Coverage 0.128 too low. | 4081af253dae5ca27b10cb9379304525 | 1023 | Pfam | PF00690 | Cation transporter/ATPase, N-terminus | 5 | 72 | 2.4E-21 | T | 22-09-2020 | IPR004014 | Cation-transporting P-type ATPase, N-terminal |
| UnnamedSample_HQ_transcript/7376|m.2977 | UnnamedSample_HQ_transcript/7376 | Coverage 0.128 too low. | 4081af253dae5ca27b10cb9379304525 | 1023 | Pfam | PF00122 | E1-E2 ATPase | 126 | 332 | 5.0E-53 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/7376|m.2977 | UnnamedSample_HQ_transcript/7376 | Coverage 0.128 too low. | 4081af253dae5ca27b10cb9379304525 | 1023 | Pfam | PF00689 | Cation transporting ATPase, C-terminus | 787 | 990 | 2.8E-42 | T | 22-09-2020 | IPR006068 | Cation-transporting P-type ATPase, C-terminal |
| UnnamedSample_HQ_transcript/7376|m.2977 | UnnamedSample_HQ_transcript/7376 | Coverage 0.128 too low. | 4081af253dae5ca27b10cb9379304525 | 1023 | Pfam | PF00702 | haloacid dehalogenase-like hydrolase | 350 | 717 | 9.2E-19 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/14175|m.5163 | UnnamedSample_HQ_transcript/14175 | Coverage 0.153 too low. | 4081af253dae5ca27b10cb9379304525 | 1023 | Pfam | PF00690 | Cation transporter/ATPase, N-terminus | 5 | 72 | 2.4E-21 | T | 22-09-2020 | IPR004014 | Cation-transporting P-type ATPase, N-terminal |
| UnnamedSample_HQ_transcript/14175|m.5163 | UnnamedSample_HQ_transcript/14175 | Coverage 0.153 too low. | 4081af253dae5ca27b10cb9379304525 | 1023 | Pfam | PF00122 | E1-E2 ATPase | 126 | 332 | 5.0E-53 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/14175|m.5163 | UnnamedSample_HQ_transcript/14175 | Coverage 0.153 too low. | 4081af253dae5ca27b10cb9379304525 | 1023 | Pfam | PF00689 | Cation transporting ATPase, C-terminus | 787 | 990 | 2.8E-42 | T | 22-09-2020 | IPR006068 | Cation-transporting P-type ATPase, C-terminal |
| UnnamedSample_HQ_transcript/14175|m.5163 | UnnamedSample_HQ_transcript/14175 | Coverage 0.153 too low. | 4081af253dae5ca27b10cb9379304525 | 1023 | Pfam | PF00702 | haloacid dehalogenase-like hydrolase | 350 | 717 | 9.2E-19 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/8662|m.3399 | UnnamedSample_HQ_transcript/8662 | Coverage 0.087 too low. | 4081af253dae5ca27b10cb9379304525 | 1023 | Pfam | PF00690 | Cation transporter/ATPase, N-terminus | 5 | 72 | 2.4E-21 | T | 22-09-2020 | IPR004014 | Cation-transporting P-type ATPase, N-terminal |
| UnnamedSample_HQ_transcript/8662|m.3399 | UnnamedSample_HQ_transcript/8662 | Coverage 0.087 too low. | 4081af253dae5ca27b10cb9379304525 | 1023 | Pfam | PF00122 | E1-E2 ATPase | 126 | 332 | 5.0E-53 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/8662|m.3399 | UnnamedSample_HQ_transcript/8662 | Coverage 0.087 too low. | 4081af253dae5ca27b10cb9379304525 | 1023 | Pfam | PF00689 | Cation transporting ATPase, C-terminus | 787 | 990 | 2.8E-42 | T | 22-09-2020 | IPR006068 | Cation-transporting P-type ATPase, C-terminal |
| UnnamedSample_HQ_transcript/8662|m.3399 | UnnamedSample_HQ_transcript/8662 | Coverage 0.087 too low. | 4081af253dae5ca27b10cb9379304525 | 1023 | Pfam | PF00702 | haloacid dehalogenase-like hydrolase | 350 | 717 | 9.2E-19 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/3669|m.1675 | UnnamedSample_HQ_transcript/3669 | Coverage 0.071 too low. | 4081af253dae5ca27b10cb9379304525 | 1023 | Pfam | PF00690 | Cation transporter/ATPase, N-terminus | 5 | 72 | 2.4E-21 | T | 22-09-2020 | IPR004014 | Cation-transporting P-type ATPase, N-terminal |
| UnnamedSample_HQ_transcript/3669|m.1675 | UnnamedSample_HQ_transcript/3669 | Coverage 0.071 too low. | 4081af253dae5ca27b10cb9379304525 | 1023 | Pfam | PF00122 | E1-E2 ATPase | 126 | 332 | 5.0E-53 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/3669|m.1675 | UnnamedSample_HQ_transcript/3669 | Coverage 0.071 too low. | 4081af253dae5ca27b10cb9379304525 | 1023 | Pfam | PF00689 | Cation transporting ATPase, C-terminus | 787 | 990 | 2.8E-42 | T | 22-09-2020 | IPR006068 | Cation-transporting P-type ATPase, C-terminal |
| UnnamedSample_HQ_transcript/3669|m.1675 | UnnamedSample_HQ_transcript/3669 | Coverage 0.071 too low. | 4081af253dae5ca27b10cb9379304525 | 1023 | Pfam | PF00702 | haloacid dehalogenase-like hydrolase | 350 | 717 | 9.2E-19 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/89706|m.21194 | UnnamedSample_HQ_transcript/89706 | Coverage 0.844 too low. | 807c246609b3e6c9d97785e8f38e95b8 | 196 | Pfam | PF01048 | Phosphorylase superfamily | 81 | 167 | 2.1E-6 | T | 22-09-2020 | IPR000845 | Nucleoside phosphorylase domain |
| UnnamedSample_HQ_transcript/31042|m.9718 | UnnamedSample_HQ_transcript/31042 | Unmapped. | f8642e36b2decb6209b3ffb57ba2835d | 466 | Pfam | PF00680 | Viral RNA-dependent RNA polymerase | 269 | 451 | 2.0E-10 | T | 22-09-2020 | IPR001205 | RNA-directed RNA polymerase, C-terminal domain |
| UnnamedSample_HQ_transcript/45296|m.12975 | UnnamedSample_HQ_transcript/45296 | Coverage 0.288 too low. | 5894b1f5e555e16b9ce326bfc4e4ea81 | 583 | Pfam | PF09334 | tRNA synthetases class I (M) | 73 | 158 | 2.8E-9 | T | 22-09-2020 | IPR015413 | Methionyl/Leucyl tRNA synthetase |
| UnnamedSample_HQ_transcript/45296|m.12975 | UnnamedSample_HQ_transcript/45296 | Coverage 0.288 too low. | 5894b1f5e555e16b9ce326bfc4e4ea81 | 583 | Pfam | PF08264 | Anticodon-binding domain of tRNA ligase | 195 | 316 | 1.5E-14 | T | 22-09-2020 | IPR013155 | Methionyl/Valyl/Leucyl/Isoleucyl-tRNA synthetase, anticodon-binding |
| UnnamedSample_HQ_transcript/21617|m.7315 | UnnamedSample_HQ_transcript/21617 | Coverage 0.958 too low. | 47af3cd051e657ce6379bbdb06951089 | 363 | Pfam | PF17900 | Peptidase M1 N-terminal domain | 21 | 181 | 3.8E-12 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/88671|m.21041 | UnnamedSample_HQ_transcript/88671 | Coverage 0.985 too low. | e306c845e827d960d616617da9f8dbea | 337 | Pfam | PF00651 | BTB/POZ domain | 229 | 325 | 8.3E-15 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/92519|m.21600 | UnnamedSample_HQ_transcript/92519 | Identity 0.899 too low. | e306c845e827d960d616617da9f8dbea | 337 | Pfam | PF00651 | BTB/POZ domain | 229 | 325 | 8.3E-15 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/72717|m.18425 | UnnamedSample_HQ_transcript/72717 | Coverage 0.904 too low. | f195028e79a64ae2ef8b4fd655a73600 | 452 | Pfam | PF00018 | SH3 domain | 32 | 81 | 1.6E-12 | T | 22-09-2020 | IPR001452 | SH3 domain |
| UnnamedSample_HQ_transcript/72717|m.18425 | UnnamedSample_HQ_transcript/72717 | Coverage 0.904 too low. | f195028e79a64ae2ef8b4fd655a73600 | 452 | Pfam | PF07714 | Protein tyrosine and serine/threonine kinase | 99 | 358 | 1.9E-67 | T | 22-09-2020 | IPR001245 | Serine-threonine/tyrosine-protein kinase, catalytic domain |
| UnnamedSample_HQ_transcript/11801|m.4424 | UnnamedSample_HQ_transcript/11801 | Coverage 0.838 too low. | 6ffc13d51b4079cfee8878bb8e19e54e | 1193 | Pfam | PF00063 | Myosin head (motor domain) | 90 | 767 | 8.2E-284 | T | 22-09-2020 | IPR001609 | Myosin head, motor domain |
| UnnamedSample_HQ_transcript/11801|m.4424 | UnnamedSample_HQ_transcript/11801 | Coverage 0.838 too low. | 6ffc13d51b4079cfee8878bb8e19e54e | 1193 | Pfam | PF01576 | Myosin tail | 847 | 1193 | 5.2E-50 | T | 22-09-2020 | IPR002928 | Myosin tail |
| UnnamedSample_HQ_transcript/11801|m.4424 | UnnamedSample_HQ_transcript/11801 | Coverage 0.838 too low. | 6ffc13d51b4079cfee8878bb8e19e54e | 1193 | Pfam | PF02736 | Myosin N-terminal SH3-like domain | 36 | 75 | 2.9E-12 | T | 22-09-2020 | IPR004009 | Myosin, N-terminal, SH3-like |
| UnnamedSample_HQ_transcript/92781|m.21632 | UnnamedSample_HQ_transcript/92781 | Coverage 0.957 too low. | 05f579d80a89a08fd82b8b4bb49f32a6 | 324 | Pfam | PF00083 | Sugar (and other) transporter | 2 | 322 | 1.7E-32 | T | 22-09-2020 | IPR005828 | Major facilitator, sugar transporter-like |
| UnnamedSample_HQ_transcript/4551|m.2019 | UnnamedSample_HQ_transcript/4551 | Coverage 0.880 too low. | fbf5d67dedaaa93d26e88b1dd297bd7c | 1045 | Pfam | PF16294 | RNSP1-SAP18 binding (RSB) motif | 922 | 1009 | 1.2E-21 | T | 22-09-2020 | IPR032552 | Acin1, RNSP1-SAP18 binding (RSB) motif |
| UnnamedSample_HQ_transcript/44648|m.12839 | UnnamedSample_HQ_transcript/44648 | Coverage 0.539 too low. | c8d519cfbb90dd4ae3e8912aab3c0835 | 659 | Pfam | PF00096 | Zinc finger, C2H2 type | 603 | 625 | 3.8E-4 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/110859|m.23945 | UnnamedSample_HQ_transcript/110859 | Coverage 0.981 too low. | 0c357618dc3fadc3458a05fbc16c86f3 | 248 | Pfam | PF00079 | Serpin (serine protease inhibitor) | 3 | 243 | 3.8E-64 | T | 22-09-2020 | IPR023796 | Serpin domain |
| UnnamedSample_HQ_transcript/60421|m.16149 | UnnamedSample_HQ_transcript/60421 | Coverage 0.978 too low. | 4365f648c3e189dd7a18bf904f85786e | 308 | Pfam | PF00651 | BTB/POZ domain | 54 | 169 | 2.8E-13 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/59149|m.15876 | UnnamedSample_HQ_transcript/59149 | Coverage 0.165 too low. | 18d98aa91140f0a078efd3b8b49d7ed8 | 209 | Pfam | PF01485 | IBR domain, a half RING-finger domain | 69 | 104 | 5.5E-8 | T | 22-09-2020 | IPR002867 | IBR domain |
| UnnamedSample_HQ_transcript/59149|m.15876 | UnnamedSample_HQ_transcript/59149 | Coverage 0.165 too low. | 18d98aa91140f0a078efd3b8b49d7ed8 | 209 | Pfam | PF01485 | IBR domain, a half RING-finger domain | 2 | 53 | 3.5E-9 | T | 22-09-2020 | IPR002867 | IBR domain |
| UnnamedSample_HQ_transcript/63455|m.16722 | UnnamedSample_HQ_transcript/63455 | Coverage 0.067 too low. | e3214e2a2db53dfe1f5dd0f90b4c7c75 | 605 | Pfam | PF17751 | SKICH domain | 49 | 143 | 2.2E-7 | T | 22-09-2020 | IPR041611 | SKICH domain |
| UnnamedSample_HQ_transcript/3570|m.1641 | UnnamedSample_HQ_transcript/3570 | Coverage 0.120 too low. | 8d982a8dbe0c9b5c8fa39ad0a8b563c2 | 1147 | Pfam | PF00621 | RhoGEF domain | 318 | 498 | 9.8E-36 | T | 22-09-2020 | IPR000219 | Dbl homology (DH) domain |
| UnnamedSample_HQ_transcript/3570|m.1641 | UnnamedSample_HQ_transcript/3570 | Coverage 0.120 too low. | 8d982a8dbe0c9b5c8fa39ad0a8b563c2 | 1147 | Pfam | PF19056 | WD40 repeated domain | 807 | 1035 | 1.3E-60 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/3570|m.1641 | UnnamedSample_HQ_transcript/3570 | Coverage 0.120 too low. | 8d982a8dbe0c9b5c8fa39ad0a8b563c2 | 1147 | Pfam | PF19057 | PH domain | 523 | 656 | 3.1E-38 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/77|m.77 | UnnamedSample_HQ_transcript/77 | Unmapped. | 6475067478de9fe293a47e765cf28337 | 1621 | Pfam | PF13087 | AAA domain | 452 | 623 | 1.5E-23 | T | 22-09-2020 | IPR041679 | DNA2/NAM7 helicase-like, C-terminal |
| UnnamedSample_HQ_transcript/40397|m.11938 | UnnamedSample_HQ_transcript/40397 | Identity 0.483 too low. | 6fc77771e1a461c7ff452ef32fe68756 | 462 | Pfam | PF00443 | Ubiquitin carboxyl-terminal hydrolase | 5 | 326 | 2.1E-25 | T | 22-09-2020 | IPR001394 | Peptidase C19, ubiquitin carboxyl-terminal hydrolase |
| UnnamedSample_HQ_transcript/10389|m.3954 | UnnamedSample_HQ_transcript/10389 | Coverage 0.712 too low. | e7728572ab7b578e8fe2ec043a3e0bed | 914 | Pfam | PF08235 | LNS2 (Lipin/Ned1/Smp2) | 658 | 883 | 2.9E-101 | T | 22-09-2020 | IPR013209 | Lipin/Ned1/Smp2 (LNS2) |
| UnnamedSample_HQ_transcript/10389|m.3954 | UnnamedSample_HQ_transcript/10389 | Coverage 0.712 too low. | e7728572ab7b578e8fe2ec043a3e0bed | 914 | Pfam | PF04571 | lipin, N-terminal conserved region | 21 | 76 | 1.1E-14 | T | 22-09-2020 | IPR007651 | Lipin, N-terminal |
| UnnamedSample_HQ_transcript/10389|m.3954 | UnnamedSample_HQ_transcript/10389 | Coverage 0.712 too low. | e7728572ab7b578e8fe2ec043a3e0bed | 914 | Pfam | PF16876 | Lipin/Ned1/Smp2 multi-domain protein middle domain | 462 | 568 | 1.7E-24 | T | 22-09-2020 | IPR031703 | Lipin, middle domain |
| UnnamedSample_HQ_transcript/10912|m.4116 | UnnamedSample_HQ_transcript/10912 | Unmapped. | 8ad1795e37696da426048b78026a122c | 1190 | Pfam | PF17222 | Viral cysteine endopeptidase C107 | 195 | 450 | 4.2E-11 | T | 22-09-2020 | IPR033777 | Viral cysteine endopeptidase C107 |
| UnnamedSample_HQ_transcript/34518|m.10609 | UnnamedSample_HQ_transcript/34518 | Coverage 0.554 too low. | 77d924790cfec1f44eba270f08d914d1 | 320 | Pfam | PF01153 | Glypican | 27 | 298 | 1.4E-45 | T | 22-09-2020 | IPR001863 | Glypican |
| UnnamedSample_HQ_transcript/49121|m.13832 | UnnamedSample_HQ_transcript/49121 | Identity 0.945 too low. | 7d086f6a0328436eb1f0cad038bc28c9 | 495 | Pfam | PF05485 | THAP domain | 78 | 136 | 4.2E-9 | T | 22-09-2020 | IPR006612 | THAP-type zinc finger |
| UnnamedSample_HQ_transcript/8919|m.3487 | UnnamedSample_HQ_transcript/8919 | Coverage 0.808 too low. | eb6c0a75be01ef06f3ba251a3dbb06ab | 999 | Pfam | PF03493 | Calcium-activated BK potassium channel alpha subunit | 472 | 568 | 7.6E-39 | T | 22-09-2020 | IPR003929 | Calcium-activated potassium channel BK, alpha subunit |
| UnnamedSample_HQ_transcript/8919|m.3487 | UnnamedSample_HQ_transcript/8919 | Coverage 0.808 too low. | eb6c0a75be01ef06f3ba251a3dbb06ab | 999 | Pfam | PF00520 | Ion transport protein | 116 | 324 | 3.6E-16 | T | 22-09-2020 | IPR005821 | Ion transport domain |
| UnnamedSample_HQ_transcript/16911|m.5976 | UnnamedSample_HQ_transcript/16911 | Identity 0.944 too low. | 5866fe1092775bb1fe42aa71226ee9e9 | 197 | Pfam | PF12605 | Casein kinase 1 gamma C terminal | 144 | 168 | 8.0E-10 | T | 22-09-2020 | IPR022247 | Casein kinase 1 gamma C-terminal |
| UnnamedSample_HQ_transcript/33435|m.10324 | UnnamedSample_HQ_transcript/33435 | Coverage 0.489 too low. | da343254fc30350db53fad71ddaca7a9 | 349 | Pfam | PF07002 | Copine | 126 | 343 | 3.2E-87 | T | 22-09-2020 | IPR010734 | Copine |
| UnnamedSample_HQ_transcript/81477|m.19951 | UnnamedSample_HQ_transcript/81477 | Coverage 0.815 too low. | faec100224e8a18ed69edfde06469bb2 | 313 | Pfam | PF00155 | Aminotransferase class I and II | 2 | 301 | 3.1E-30 | T | 22-09-2020 | IPR004839 | Aminotransferase, class I/classII |
| UnnamedSample_HQ_transcript/119650|m.24817 | UnnamedSample_HQ_transcript/119650 | Coverage 0.615 too low. | a1685ff331ea80b2a3ac44823430ce0f | 152 | Pfam | PF05199 | GMC oxidoreductase | 2 | 138 | 2.0E-36 | T | 22-09-2020 | IPR007867 | Glucose-methanol-choline oxidoreductase, C-terminal |
| UnnamedSample_HQ_transcript/11568|m.4345 | UnnamedSample_HQ_transcript/11568 | Coverage 0.061 too low. | 47d16c6a4f66ee53876aa2295e980031 | 1004 | Pfam | PF00105 | Zinc finger, C4 type (two domains) | 52 | 121 | 6.1E-31 | T | 22-09-2020 | IPR001628 | Zinc finger, nuclear hormone receptor-type |
| UnnamedSample_HQ_transcript/11568|m.4345 | UnnamedSample_HQ_transcript/11568 | Coverage 0.061 too low. | 47d16c6a4f66ee53876aa2295e980031 | 1004 | Pfam | PF00104 | Ligand-binding domain of nuclear hormone receptor | 222 | 396 | 4.1E-19 | T | 22-09-2020 | IPR000536 | Nuclear hormone receptor, ligand-binding domain |
| UnnamedSample_HQ_transcript/47687|m.13506 | UnnamedSample_HQ_transcript/47687 | Identity 0.923 too low. | 678479b96603ea007f9ae76fa1fa64da | 705 | Pfam | PF01433 | Peptidase family M1 domain | 7 | 236 | 2.0E-32 | T | 22-09-2020 | IPR014782 | Peptidase M1, membrane alanine aminopeptidase |
| UnnamedSample_HQ_transcript/47687|m.13506 | UnnamedSample_HQ_transcript/47687 | Identity 0.923 too low. | 678479b96603ea007f9ae76fa1fa64da | 705 | Pfam | PF11838 | ERAP1-like C-terminal domain | 316 | 588 | 5.7E-46 | T | 22-09-2020 | IPR024571 | ERAP1-like C-terminal domain |
| UnnamedSample_HQ_transcript/46988|m.13363 | UnnamedSample_HQ_transcript/46988 | Unmapped. | ecdb59d764ed2117bef069dc63987332 | 584 | Pfam | PF17222 | Viral cysteine endopeptidase C107 | 8 | 263 | 1.4E-11 | T | 22-09-2020 | IPR033777 | Viral cysteine endopeptidase C107 |
| UnnamedSample_HQ_transcript/1127|m.695 | UnnamedSample_HQ_transcript/1127 | Coverage 0.020 too low. | 1af6c5033784a506c17babd2e07c5067 | 997 | Pfam | PF00109 | Beta-ketoacyl synthase, N-terminal domain | 2 | 41 | 4.3E-7 | T | 22-09-2020 | IPR014030 | Beta-ketoacyl synthase, N-terminal |
| UnnamedSample_HQ_transcript/1127|m.695 | UnnamedSample_HQ_transcript/1127 | Coverage 0.020 too low. | 1af6c5033784a506c17babd2e07c5067 | 997 | Pfam | PF14765 | Polyketide synthase dehydratase | 678 | 844 | 1.6E-6 | T | 22-09-2020 | IPR020807 | Polyketide synthase, dehydratase domain |
| UnnamedSample_HQ_transcript/1127|m.695 | UnnamedSample_HQ_transcript/1127 | Coverage 0.020 too low. | 1af6c5033784a506c17babd2e07c5067 | 997 | Pfam | PF02801 | Beta-ketoacyl synthase, C-terminal domain | 45 | 172 | 1.9E-28 | T | 22-09-2020 | IPR014031 | Beta-ketoacyl synthase, C-terminal |
| UnnamedSample_HQ_transcript/1127|m.695 | UnnamedSample_HQ_transcript/1127 | Coverage 0.020 too low. | 1af6c5033784a506c17babd2e07c5067 | 997 | Pfam | PF16197 | Ketoacyl-synthetase C-terminal extension | 175 | 285 | 1.5E-33 | T | 22-09-2020 | IPR032821 | Polyketide synthase, C-terminal extension |
| UnnamedSample_HQ_transcript/1127|m.695 | UnnamedSample_HQ_transcript/1127 | Coverage 0.020 too low. | 1af6c5033784a506c17babd2e07c5067 | 997 | Pfam | PF00698 | Acyl transferase domain | 309 | 622 | 1.1E-69 | T | 22-09-2020 | IPR014043 | Acyl transferase |
| UnnamedSample_HQ_transcript/14253|m.5186 | UnnamedSample_HQ_transcript/14253 | Unmapped. | 4b362fbb8b9f4506e63e1dab229c1546 | 1193 | Pfam | PF00910 | RNA helicase | 242 | 350 | 4.0E-18 | T | 22-09-2020 | IPR000605 | Helicase, superfamily 3, single-stranded DNA/RNA virus |
| UnnamedSample_HQ_transcript/8091|m.3220 | UnnamedSample_HQ_transcript/8091 | Coverage 0.273 too low. | b1fa6ad01ff2578bfbc3548008282fd6 | 198 | Pfam | PF16209 | Phospholipid-translocating ATPase N-terminal | 48 | 108 | 1.8E-26 | T | 22-09-2020 | IPR032631 | P-type ATPase, N-terminal |
| UnnamedSample_HQ_transcript/16389|m.5825 | UnnamedSample_HQ_transcript/16389 | Coverage 0.940 too low. | ec41c843ca531652f407f84ea8e91259 | 1075 | Pfam | PF01590 | GAF domain | 435 | 524 | 2.4E-12 | T | 22-09-2020 | IPR003018 | GAF domain |
| UnnamedSample_HQ_transcript/16389|m.5825 | UnnamedSample_HQ_transcript/16389 | Coverage 0.940 too low. | ec41c843ca531652f407f84ea8e91259 | 1075 | Pfam | PF01590 | GAF domain | 562 | 707 | 9.2E-15 | T | 22-09-2020 | IPR003018 | GAF domain |
| UnnamedSample_HQ_transcript/16389|m.5825 | UnnamedSample_HQ_transcript/16389 | Coverage 0.940 too low. | ec41c843ca531652f407f84ea8e91259 | 1075 | Pfam | PF00233 | 3'5'-cyclic nucleotide phosphodiesterase | 813 | 1047 | 5.2E-77 | T | 22-09-2020 | IPR002073 | 3'5'-cyclic nucleotide phosphodiesterase, catalytic domain |
| UnnamedSample_HQ_transcript/741|m.513 | UnnamedSample_HQ_transcript/741 | Coverage 0.544 too low. | 491f6bdb416d8adefa1655515cfcb96f | 1329 | Pfam | PF00630 | Filamin/ABP280 repeat | 831 | 913 | 2.3E-7 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/741|m.513 | UnnamedSample_HQ_transcript/741 | Coverage 0.544 too low. | 491f6bdb416d8adefa1655515cfcb96f | 1329 | Pfam | PF00630 | Filamin/ABP280 repeat | 1238 | 1326 | 4.1E-12 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/741|m.513 | UnnamedSample_HQ_transcript/741 | Coverage 0.544 too low. | 491f6bdb416d8adefa1655515cfcb96f | 1329 | Pfam | PF00630 | Filamin/ABP280 repeat | 924 | 1008 | 2.9E-16 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/741|m.513 | UnnamedSample_HQ_transcript/741 | Coverage 0.544 too low. | 491f6bdb416d8adefa1655515cfcb96f | 1329 | Pfam | PF00630 | Filamin/ABP280 repeat | 729 | 815 | 6.1E-15 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/741|m.513 | UnnamedSample_HQ_transcript/741 | Coverage 0.544 too low. | 491f6bdb416d8adefa1655515cfcb96f | 1329 | Pfam | PF00630 | Filamin/ABP280 repeat | 255 | 346 | 1.6E-13 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/741|m.513 | UnnamedSample_HQ_transcript/741 | Coverage 0.544 too low. | 491f6bdb416d8adefa1655515cfcb96f | 1329 | Pfam | PF00630 | Filamin/ABP280 repeat | 486 | 540 | 1.3E-8 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/741|m.513 | UnnamedSample_HQ_transcript/741 | Coverage 0.544 too low. | 491f6bdb416d8adefa1655515cfcb96f | 1329 | Pfam | PF00630 | Filamin/ABP280 repeat | 65 | 151 | 5.4E-20 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/741|m.513 | UnnamedSample_HQ_transcript/741 | Coverage 0.544 too low. | 491f6bdb416d8adefa1655515cfcb96f | 1329 | Pfam | PF00630 | Filamin/ABP280 repeat | 550 | 632 | 1.1E-18 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/741|m.513 | UnnamedSample_HQ_transcript/741 | Coverage 0.544 too low. | 491f6bdb416d8adefa1655515cfcb96f | 1329 | Pfam | PF00630 | Filamin/ABP280 repeat | 1111 | 1196 | 8.2E-12 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/741|m.513 | UnnamedSample_HQ_transcript/741 | Coverage 0.544 too low. | 491f6bdb416d8adefa1655515cfcb96f | 1329 | Pfam | PF00630 | Filamin/ABP280 repeat | 4 | 57 | 1.2E-10 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/741|m.513 | UnnamedSample_HQ_transcript/741 | Coverage 0.544 too low. | 491f6bdb416d8adefa1655515cfcb96f | 1329 | Pfam | PF00630 | Filamin/ABP280 repeat | 158 | 248 | 3.2E-14 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/741|m.513 | UnnamedSample_HQ_transcript/741 | Coverage 0.544 too low. | 491f6bdb416d8adefa1655515cfcb96f | 1329 | Pfam | PF00630 | Filamin/ABP280 repeat | 358 | 437 | 7.3E-12 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/741|m.513 | UnnamedSample_HQ_transcript/741 | Coverage 0.544 too low. | 491f6bdb416d8adefa1655515cfcb96f | 1329 | Pfam | PF00630 | Filamin/ABP280 repeat | 1030 | 1102 | 9.4E-7 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/19948|m.6855 | UnnamedSample_HQ_transcript/19948 | Coverage 0.971 too low. | 24d583599e972f15bc3eb3c507a4b059 | 1053 | Pfam | PF05485 | THAP domain | 4 | 88 | 7.3E-12 | T | 22-09-2020 | IPR006612 | THAP-type zinc finger |
| UnnamedSample_HQ_transcript/20035|m.6881 | UnnamedSample_HQ_transcript/20035 | Coverage 0.978 too low. | 24d583599e972f15bc3eb3c507a4b059 | 1053 | Pfam | PF05485 | THAP domain | 4 | 88 | 7.3E-12 | T | 22-09-2020 | IPR006612 | THAP-type zinc finger |
| UnnamedSample_HQ_transcript/18299|m.6394 | UnnamedSample_HQ_transcript/18299 | Coverage 0.955 too low. | 24d583599e972f15bc3eb3c507a4b059 | 1053 | Pfam | PF05485 | THAP domain | 4 | 88 | 7.3E-12 | T | 22-09-2020 | IPR006612 | THAP-type zinc finger |
| UnnamedSample_HQ_transcript/41317|m.12119 | UnnamedSample_HQ_transcript/41317 | Coverage 0.552 too low. | 426218d099ee7572d85e8083d7bf8be7 | 679 | Pfam | PF09820 | Predicted AAA-ATPase | 93 | 384 | 2.4E-52 | T | 22-09-2020 | IPR018631 | AAA-ATPase-like domain |
| UnnamedSample_HQ_transcript/60885|m.16235 | UnnamedSample_HQ_transcript/60885 | Coverage 0.185 too low. | a1d4e616b3d1d1185f24e0aeeb07f88e | 524 | Pfam | PF00372 | Hemocyanin, copper containing domain | 1 | 180 | 2.8E-34 | T | 22-09-2020 | IPR000896 | Hemocyanin/hexamerin middle domain |
| UnnamedSample_HQ_transcript/60885|m.16235 | UnnamedSample_HQ_transcript/60885 | Coverage 0.185 too low. | a1d4e616b3d1d1185f24e0aeeb07f88e | 524 | Pfam | PF03723 | Hemocyanin, ig-like domain | 190 | 456 | 2.2E-63 | T | 22-09-2020 | IPR005203 | Hemocyanin, C-terminal |
| UnnamedSample_HQ_transcript/65065|m.17042 | UnnamedSample_HQ_transcript/65065 | Coverage 0.873 too low. | a1d4e616b3d1d1185f24e0aeeb07f88e | 524 | Pfam | PF00372 | Hemocyanin, copper containing domain | 1 | 180 | 2.8E-34 | T | 22-09-2020 | IPR000896 | Hemocyanin/hexamerin middle domain |
| UnnamedSample_HQ_transcript/65065|m.17042 | UnnamedSample_HQ_transcript/65065 | Coverage 0.873 too low. | a1d4e616b3d1d1185f24e0aeeb07f88e | 524 | Pfam | PF03723 | Hemocyanin, ig-like domain | 190 | 456 | 2.2E-63 | T | 22-09-2020 | IPR005203 | Hemocyanin, C-terminal |
| UnnamedSample_HQ_transcript/65786|m.17163 | UnnamedSample_HQ_transcript/65786 | Coverage 0.904 too low. | a1d4e616b3d1d1185f24e0aeeb07f88e | 524 | Pfam | PF00372 | Hemocyanin, copper containing domain | 1 | 180 | 2.8E-34 | T | 22-09-2020 | IPR000896 | Hemocyanin/hexamerin middle domain |
| UnnamedSample_HQ_transcript/65786|m.17163 | UnnamedSample_HQ_transcript/65786 | Coverage 0.904 too low. | a1d4e616b3d1d1185f24e0aeeb07f88e | 524 | Pfam | PF03723 | Hemocyanin, ig-like domain | 190 | 456 | 2.2E-63 | T | 22-09-2020 | IPR005203 | Hemocyanin, C-terminal |
| UnnamedSample_HQ_transcript/3408|m.1594 | UnnamedSample_HQ_transcript/3408 | Identity 0.761 too low. | 8469b5b0a3503ab4d33985e840d1f191 | 631 | Pfam | PF01753 | MYND finger | 592 | 629 | 2.7E-8 | T | 22-09-2020 | IPR002893 | Zinc finger, MYND-type |
| UnnamedSample_HQ_transcript/3889|m.1770 | UnnamedSample_HQ_transcript/3889 | Coverage 0.364 too low. | f7293a5f530007a1cac6fea10e68e7d3 | 490 | Pfam | PF00443 | Ubiquitin carboxyl-terminal hydrolase | 76 | 473 | 2.9E-45 | T | 22-09-2020 | IPR001394 | Peptidase C19, ubiquitin carboxyl-terminal hydrolase |
| UnnamedSample_HQ_transcript/392|m.303 | UnnamedSample_HQ_transcript/392 | Coverage 0.265 too low. | f7293a5f530007a1cac6fea10e68e7d3 | 490 | Pfam | PF00443 | Ubiquitin carboxyl-terminal hydrolase | 76 | 473 | 2.9E-45 | T | 22-09-2020 | IPR001394 | Peptidase C19, ubiquitin carboxyl-terminal hydrolase |
| UnnamedSample_HQ_transcript/2127|m.1104 | UnnamedSample_HQ_transcript/2127 | Coverage 0.320 too low. | f7293a5f530007a1cac6fea10e68e7d3 | 490 | Pfam | PF00443 | Ubiquitin carboxyl-terminal hydrolase | 76 | 473 | 2.9E-45 | T | 22-09-2020 | IPR001394 | Peptidase C19, ubiquitin carboxyl-terminal hydrolase |
| UnnamedSample_HQ_transcript/2125|m.1103 | UnnamedSample_HQ_transcript/2125 | Coverage 0.357 too low. | f7293a5f530007a1cac6fea10e68e7d3 | 490 | Pfam | PF00443 | Ubiquitin carboxyl-terminal hydrolase | 76 | 473 | 2.9E-45 | T | 22-09-2020 | IPR001394 | Peptidase C19, ubiquitin carboxyl-terminal hydrolase |
| UnnamedSample_HQ_transcript/2636|m.1291 | UnnamedSample_HQ_transcript/2636 | Coverage 0.372 too low. | f7293a5f530007a1cac6fea10e68e7d3 | 490 | Pfam | PF00443 | Ubiquitin carboxyl-terminal hydrolase | 76 | 473 | 2.9E-45 | T | 22-09-2020 | IPR001394 | Peptidase C19, ubiquitin carboxyl-terminal hydrolase |
| UnnamedSample_HQ_transcript/41257|m.12108 | UnnamedSample_HQ_transcript/41257 | Identity 0.757 too low. | d571dd9f7c3bcb399fb064bf77d5ed57 | 624 | Pfam | PF00271 | Helicase conserved C-terminal domain | 320 | 432 | 3.3E-20 | T | 22-09-2020 | IPR001650 | Helicase, C-terminal |
| UnnamedSample_HQ_transcript/41257|m.12108 | UnnamedSample_HQ_transcript/41257 | Identity 0.757 too low. | d571dd9f7c3bcb399fb064bf77d5ed57 | 624 | Pfam | PF00176 | SNF2 family N-terminal domain | 25 | 293 | 2.8E-63 | T | 22-09-2020 | IPR000330 | SNF2-related, N-terminal domain |
| UnnamedSample_HQ_transcript/5822|m.2467 | UnnamedSample_HQ_transcript/5822 | Coverage 0.726 too low. | 0cd29dfd87335c988600d7354d5ba00e | 729 | Pfam | PF02373 | JmjC domain, hydroxylase | 528 | 636 | 2.0E-29 | T | 22-09-2020 | IPR003347 | JmjC domain |
| UnnamedSample_HQ_transcript/22959|m.7679 | UnnamedSample_HQ_transcript/22959 | Coverage 0.660 too low. | 6e0ea2b51a0bbdd9046848ce02c8300f | 483 | Pfam | PF00400 | WD domain, G-beta repeat | 182 | 206 | 0.0025 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/6984|m.2854 | UnnamedSample_HQ_transcript/6984 | Coverage 0.902 too low. | 54f7f7055d322b2cb8b73fdc834a62bd | 1218 | Pfam | PF00397 | WW domain | 306 | 335 | 1.3E-7 | T | 22-09-2020 | IPR001202 | WW domain |
| UnnamedSample_HQ_transcript/6984|m.2854 | UnnamedSample_HQ_transcript/6984 | Coverage 0.902 too low. | 54f7f7055d322b2cb8b73fdc834a62bd | 1218 | Pfam | PF00595 | PDZ domain | 881 | 960 | 1.7E-13 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/6984|m.2854 | UnnamedSample_HQ_transcript/6984 | Coverage 0.902 too low. | 54f7f7055d322b2cb8b73fdc834a62bd | 1218 | Pfam | PF00595 | PDZ domain | 984 | 1061 | 6.9E-14 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/6984|m.2854 | UnnamedSample_HQ_transcript/6984 | Coverage 0.902 too low. | 54f7f7055d322b2cb8b73fdc834a62bd | 1218 | Pfam | PF00595 | PDZ domain | 1092 | 1170 | 2.3E-15 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/6984|m.2854 | UnnamedSample_HQ_transcript/6984 | Coverage 0.902 too low. | 54f7f7055d322b2cb8b73fdc834a62bd | 1218 | Pfam | PF00595 | PDZ domain | 454 | 517 | 7.4E-7 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/6984|m.2854 | UnnamedSample_HQ_transcript/6984 | Coverage 0.902 too low. | 54f7f7055d322b2cb8b73fdc834a62bd | 1218 | Pfam | PF00595 | PDZ domain | 625 | 689 | 2.0E-5 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/6984|m.2854 | UnnamedSample_HQ_transcript/6984 | Coverage 0.902 too low. | 54f7f7055d322b2cb8b73fdc834a62bd | 1218 | Pfam | PF00625 | Guanylate kinase | 158 | 208 | 2.2E-8 | T | 22-09-2020 | IPR008145 | Guanylate kinase/L-type calcium channel beta subunit |
| UnnamedSample_HQ_transcript/113070|m.24194 | UnnamedSample_HQ_transcript/113070 | Coverage 0.986 too low. | 1d5102590b5986e2a2556306306689f0 | 215 | Pfam | PF13410 | Glutathione S-transferase, C-terminal domain | 113 | 176 | 1.5E-7 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/113070|m.24194 | UnnamedSample_HQ_transcript/113070 | Coverage 0.986 too low. | 1d5102590b5986e2a2556306306689f0 | 215 | Pfam | PF13417 | Glutathione S-transferase, N-terminal domain | 1 | 71 | 3.6E-14 | T | 22-09-2020 | IPR004045 | Glutathione S-transferase, N-terminal |
| UnnamedSample_HQ_transcript/35735|m.10867 | UnnamedSample_HQ_transcript/35735 | Coverage 0.772 too low. | d0f7639372f0ee3286d0324b5192d47f | 159 | Pfam | PF00135 | Carboxylesterase family | 4 | 83 | 1.9E-5 | T | 22-09-2020 | IPR002018 | Carboxylesterase, type B |
| UnnamedSample_HQ_transcript/8|m.9 | UnnamedSample_HQ_transcript/8 | Unmapped. | 702c0ccf44ee92810953f053a53dd6e9 | 1075 | Pfam | PF13087 | AAA domain | 5 | 77 | 4.8E-10 | T | 22-09-2020 | IPR041679 | DNA2/NAM7 helicase-like, C-terminal |
| UnnamedSample_HQ_transcript/19421|m.6708 | UnnamedSample_HQ_transcript/19421 | Unmapped. | 702c0ccf44ee92810953f053a53dd6e9 | 1075 | Pfam | PF13087 | AAA domain | 5 | 77 | 4.8E-10 | T | 22-09-2020 | IPR041679 | DNA2/NAM7 helicase-like, C-terminal |
| UnnamedSample_HQ_transcript/37270|m.11223 | UnnamedSample_HQ_transcript/37270 | Coverage 0.928 too low. | 29a5aedb50dbddb8627d7551c6a110a5 | 507 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 30 | 88 | 8.5E-12 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/37270|m.11223 | UnnamedSample_HQ_transcript/37270 | Coverage 0.928 too low. | 29a5aedb50dbddb8627d7551c6a110a5 | 507 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 121 | 173 | 7.9E-12 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/63606|m.16758 | UnnamedSample_HQ_transcript/63606 | Coverage 0.977 too low. | 29a5aedb50dbddb8627d7551c6a110a5 | 507 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 30 | 88 | 8.5E-12 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/63606|m.16758 | UnnamedSample_HQ_transcript/63606 | Coverage 0.977 too low. | 29a5aedb50dbddb8627d7551c6a110a5 | 507 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 121 | 173 | 7.9E-12 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/53011|m.14646 | UnnamedSample_HQ_transcript/53011 | Coverage 0.915 too low. | 29a5aedb50dbddb8627d7551c6a110a5 | 507 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 30 | 88 | 8.5E-12 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/53011|m.14646 | UnnamedSample_HQ_transcript/53011 | Coverage 0.915 too low. | 29a5aedb50dbddb8627d7551c6a110a5 | 507 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 121 | 173 | 7.9E-12 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/59675|m.15994 | UnnamedSample_HQ_transcript/59675 | Coverage 0.908 too low. | 29a5aedb50dbddb8627d7551c6a110a5 | 507 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 30 | 88 | 8.5E-12 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/59675|m.15994 | UnnamedSample_HQ_transcript/59675 | Coverage 0.908 too low. | 29a5aedb50dbddb8627d7551c6a110a5 | 507 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 121 | 173 | 7.9E-12 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/58570|m.15769 | UnnamedSample_HQ_transcript/58570 | Coverage 0.908 too low. | 29a5aedb50dbddb8627d7551c6a110a5 | 507 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 30 | 88 | 8.5E-12 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/58570|m.15769 | UnnamedSample_HQ_transcript/58570 | Coverage 0.908 too low. | 29a5aedb50dbddb8627d7551c6a110a5 | 507 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 121 | 173 | 7.9E-12 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/45106|m.12932 | UnnamedSample_HQ_transcript/45106 | Coverage 0.590 too low. | cdeccaba0262c62b930512e178a6c3fe | 404 | Pfam | PF13520 | Amino acid permease | 40 | 386 | 3.5E-41 | T | 22-09-2020 | IPR002293 | Amino acid/polyamine transporter I |
| UnnamedSample_HQ_transcript/4385|m.1952 | UnnamedSample_HQ_transcript/4385 | Coverage 0.810 too low. | 68866a49648308b953e71cbe80c26826 | 1431 | Pfam | PF00443 | Ubiquitin carboxyl-terminal hydrolase | 91 | 419 | 7.5E-44 | T | 22-09-2020 | IPR001394 | Peptidase C19, ubiquitin carboxyl-terminal hydrolase |
| UnnamedSample_HQ_transcript/7036|m.2873 | UnnamedSample_HQ_transcript/7036 | Coverage 0.365 too low. | 32807d9cb746da10f1bf0aea76ee60b1 | 715 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 357 | 431 | 1.6E-5 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/9541|m.3687 | UnnamedSample_HQ_transcript/9541 | Coverage 0.394 too low. | 32807d9cb746da10f1bf0aea76ee60b1 | 715 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 357 | 431 | 1.6E-5 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/13736|m.5028 | UnnamedSample_HQ_transcript/13736 | Coverage 0.429 too low. | 32807d9cb746da10f1bf0aea76ee60b1 | 715 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 357 | 431 | 1.6E-5 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/9410|m.3643 | UnnamedSample_HQ_transcript/9410 | Coverage 0.220 too low. | eb521d7aa5eaa80e9bc84c709e5fc0b2 | 1035 | Pfam | PF00567 | Tudor domain | 850 | 958 | 1.2E-12 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/9219|m.3577 | UnnamedSample_HQ_transcript/9219 | Unmapped. | eaabcddf212bcfe32ae175d0d95d660e | 1190 | Pfam | PF00680 | Viral RNA-dependent RNA polymerase | 491 | 859 | 1.6E-9 | T | 22-09-2020 | IPR001205 | RNA-directed RNA polymerase, C-terminal domain |
| UnnamedSample_HQ_transcript/1147|m.704 | UnnamedSample_HQ_transcript/1147 | Unmapped. | eaabcddf212bcfe32ae175d0d95d660e | 1190 | Pfam | PF00680 | Viral RNA-dependent RNA polymerase | 491 | 859 | 1.6E-9 | T | 22-09-2020 | IPR001205 | RNA-directed RNA polymerase, C-terminal domain |
| UnnamedSample_HQ_transcript/26498|m.8604 | UnnamedSample_HQ_transcript/26498 | Coverage 0.720 too low. | 24c4bcf453f342366a98ffaec992ad09 | 450 | Pfam | PF00013 | KH domain | 292 | 348 | 2.9E-6 | T | 22-09-2020 | IPR004088 | K Homology domain, type 1 |
| UnnamedSample_HQ_transcript/26498|m.8604 | UnnamedSample_HQ_transcript/26498 | Coverage 0.720 too low. | 24c4bcf453f342366a98ffaec992ad09 | 450 | Pfam | PF01138 | 3' exoribonuclease family, domain 1 | 48 | 183 | 2.5E-22 | T | 22-09-2020 | IPR001247 | Exoribonuclease, phosphorolytic domain 1 |
| UnnamedSample_HQ_transcript/108957|m.23705 | UnnamedSample_HQ_transcript/108957 | Coverage 0.681 too low. | 13e35c426fd08dd58b42dd8fb569f6b4 | 257 | Pfam | PF13625 | Helicase conserved C-terminal domain | 78 | 203 | 4.7E-37 | T | 22-09-2020 | IPR032830 | Helicase XPB/Ssl2, N-terminal domain |
| UnnamedSample_HQ_transcript/18155|m.6352 | UnnamedSample_HQ_transcript/18155 | Coverage 0.490 too low. | 3314ce7fc9f3a3ba0c75fd9eecfcd980 | 670 | Pfam | PF07679 | Immunoglobulin I-set domain | 146 | 239 | 2.7E-6 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/18155|m.6352 | UnnamedSample_HQ_transcript/18155 | Coverage 0.490 too low. | 3314ce7fc9f3a3ba0c75fd9eecfcd980 | 670 | Pfam | PF00041 | Fibronectin type III domain | 458 | 542 | 5.7E-10 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/18155|m.6352 | UnnamedSample_HQ_transcript/18155 | Coverage 0.490 too low. | 3314ce7fc9f3a3ba0c75fd9eecfcd980 | 670 | Pfam | PF00041 | Fibronectin type III domain | 341 | 424 | 5.7E-9 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/18155|m.6352 | UnnamedSample_HQ_transcript/18155 | Coverage 0.490 too low. | 3314ce7fc9f3a3ba0c75fd9eecfcd980 | 670 | Pfam | PF13927 | Immunoglobulin domain | 53 | 123 | 2.2E-14 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/18155|m.6352 | UnnamedSample_HQ_transcript/18155 | Coverage 0.490 too low. | 3314ce7fc9f3a3ba0c75fd9eecfcd980 | 670 | Pfam | PF13927 | Immunoglobulin domain | 258 | 322 | 1.9E-9 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/12519|m.4669 | UnnamedSample_HQ_transcript/12519 | Coverage 0.442 too low. | 3314ce7fc9f3a3ba0c75fd9eecfcd980 | 670 | Pfam | PF07679 | Immunoglobulin I-set domain | 146 | 239 | 2.7E-6 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/12519|m.4669 | UnnamedSample_HQ_transcript/12519 | Coverage 0.442 too low. | 3314ce7fc9f3a3ba0c75fd9eecfcd980 | 670 | Pfam | PF00041 | Fibronectin type III domain | 458 | 542 | 5.7E-10 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/12519|m.4669 | UnnamedSample_HQ_transcript/12519 | Coverage 0.442 too low. | 3314ce7fc9f3a3ba0c75fd9eecfcd980 | 670 | Pfam | PF00041 | Fibronectin type III domain | 341 | 424 | 5.7E-9 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/12519|m.4669 | UnnamedSample_HQ_transcript/12519 | Coverage 0.442 too low. | 3314ce7fc9f3a3ba0c75fd9eecfcd980 | 670 | Pfam | PF13927 | Immunoglobulin domain | 53 | 123 | 2.2E-14 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/12519|m.4669 | UnnamedSample_HQ_transcript/12519 | Coverage 0.442 too low. | 3314ce7fc9f3a3ba0c75fd9eecfcd980 | 670 | Pfam | PF13927 | Immunoglobulin domain | 258 | 322 | 1.9E-9 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/28485|m.9088 | UnnamedSample_HQ_transcript/28485 | Coverage 0.681 too low. | 9fc4f1c134841bedba69dcbcf3aa1725 | 892 | Pfam | PF13476 | AAA domain | 86 | 360 | 1.4E-13 | T | 22-09-2020 | IPR038729 | Rad50/SbcC-type AAA domain |
| UnnamedSample_HQ_transcript/58479|m.15744 | UnnamedSample_HQ_transcript/58479 | Identity 0.809 too low. | 0fb1e952dff814d3b85e5127a1bb0407 | 633 | Pfam | PF00788 | Ras association (RalGDS/AF-6) domain | 517 | 604 | 1.3E-14 | T | 22-09-2020 | IPR000159 | Ras-associating (RA) domain |
| UnnamedSample_HQ_transcript/58479|m.15744 | UnnamedSample_HQ_transcript/58479 | Identity 0.809 too low. | 0fb1e952dff814d3b85e5127a1bb0407 | 633 | Pfam | PF00617 | RasGEF domain | 119 | 331 | 7.9E-58 | T | 22-09-2020 | IPR001895 | Ras guanine-nucleotide exchange factors catalytic domain |
| UnnamedSample_HQ_transcript/52042|m.14463 | UnnamedSample_HQ_transcript/52042 | Coverage 0.256 too low. | 3af0cbcd0de69e831100298c8d252ef8 | 589 | Pfam | PF02198 | Sterile alpha motif (SAM)/Pointed domain | 124 | 205 | 8.0E-32 | T | 22-09-2020 | IPR003118 | Pointed domain |
| UnnamedSample_HQ_transcript/52042|m.14463 | UnnamedSample_HQ_transcript/52042 | Coverage 0.256 too low. | 3af0cbcd0de69e831100298c8d252ef8 | 589 | Pfam | PF00178 | Ets-domain | 539 | 589 | 2.3E-17 | T | 22-09-2020 | IPR000418 | Ets domain |
| UnnamedSample_HQ_transcript/92191|m.21561 | UnnamedSample_HQ_transcript/92191 | Coverage 0.816 too low. | 5e1b2ab2e70bf115f48aca1cfd86510b | 297 | Pfam | PF01459 | Eukaryotic porin | 8 | 280 | 2.0E-49 | T | 22-09-2020 | IPR027246 | Eukaryotic porin/Tom40 |
| UnnamedSample_HQ_transcript/63855|m.16813 | UnnamedSample_HQ_transcript/63855 | Identity 0.519 too low. | 50b3804d1431b4ae1b62fb2641d18558 | 183 | Pfam | PF00625 | Guanylate kinase | 3 | 167 | 5.3E-13 | T | 22-09-2020 | IPR008145 | Guanylate kinase/L-type calcium channel beta subunit |
| UnnamedSample_HQ_transcript/99070|m.22504 | UnnamedSample_HQ_transcript/99070 | Unmapped. | 72af3e5619546b5e7fdd924898653ece | 173 | Pfam | PF00118 | TCP-1/cpn60 chaperonin family | 3 | 170 | 4.2E-16 | T | 22-09-2020 | IPR002423 | Chaperonin Cpn60/TCP-1 family |
| UnnamedSample_HQ_transcript/120874|m.24912 | UnnamedSample_HQ_transcript/120874 | Unmapped. | 72af3e5619546b5e7fdd924898653ece | 173 | Pfam | PF00118 | TCP-1/cpn60 chaperonin family | 3 | 170 | 4.2E-16 | T | 22-09-2020 | IPR002423 | Chaperonin Cpn60/TCP-1 family |
| UnnamedSample_HQ_transcript/104137|m.23123 | UnnamedSample_HQ_transcript/104137 | Coverage 0.849 too low. | 47df16a8eab1b8ee061aef3bdba4d8d2 | 293 | Pfam | PF13499 | EF-hand domain pair | 46 | 120 | 9.6E-8 | T | 22-09-2020 | IPR002048 | EF-hand domain |
| UnnamedSample_HQ_transcript/104137|m.23123 | UnnamedSample_HQ_transcript/104137 | Coverage 0.849 too low. | 47df16a8eab1b8ee061aef3bdba4d8d2 | 293 | Pfam | PF13499 | EF-hand domain pair | 143 | 212 | 2.1E-10 | T | 22-09-2020 | IPR002048 | EF-hand domain |
| UnnamedSample_HQ_transcript/104137|m.23123 | UnnamedSample_HQ_transcript/104137 | Coverage 0.849 too low. | 47df16a8eab1b8ee061aef3bdba4d8d2 | 293 | Pfam | PF00036 | EF hand | 236 | 263 | 1.7E-6 | T | 22-09-2020 | IPR002048 | EF-hand domain |
| UnnamedSample_HQ_transcript/26075|m.8497 | UnnamedSample_HQ_transcript/26075 | Coverage 0.439 too low. | 5045abe8a4e4d2747ec2ae533b4af114 | 280 | Pfam | PF00046 | Homeodomain | 50 | 95 | 1.9E-5 | T | 22-09-2020 | IPR001356 | Homeobox domain |
| UnnamedSample_HQ_transcript/34979|m.10715 | UnnamedSample_HQ_transcript/34979 | Identity 0.949 too low. | b11a4e8d0dc0d9af40ce4d633709a6ec | 353 | Pfam | PF16212 | Phospholipid-translocating P-type ATPase C-terminal | 21 | 269 | 1.8E-75 | T | 22-09-2020 | IPR032630 | P-type ATPase, C-terminal |
| UnnamedSample_HQ_transcript/4344|m.1934 | UnnamedSample_HQ_transcript/4344 | Coverage 0.095 too low. | f78f1c892318add5d3f8d3ba819a39a1 | 717 | Pfam | PF12448 | Kinesin associated protein | 312 | 456 | 3.5E-20 | T | 22-09-2020 | IPR022154 | Trafficking kinesin-binding protein, C-terminal |
| UnnamedSample_HQ_transcript/4344|m.1934 | UnnamedSample_HQ_transcript/4344 | Coverage 0.095 too low. | f78f1c892318add5d3f8d3ba819a39a1 | 717 | Pfam | PF04849 | HAP1 N-terminal conserved region | 1 | 237 | 3.3E-65 | T | 22-09-2020 | IPR006933 | HAP1, N-terminal |
| UnnamedSample_HQ_transcript/9409|m.3642 | UnnamedSample_HQ_transcript/9409 | Coverage 0.491 too low. | 378dcdd68ccff9258ea43e2d879db7e8 | 1248 | Pfam | PF13855 | Leucine rich repeat | 267 | 303 | 2.7E-6 | T | 22-09-2020 | IPR001611 | Leucine-rich repeat |
| UnnamedSample_HQ_transcript/9409|m.3642 | UnnamedSample_HQ_transcript/9409 | Coverage 0.491 too low. | 378dcdd68ccff9258ea43e2d879db7e8 | 1248 | Pfam | PF13855 | Leucine rich repeat | 33 | 90 | 1.7E-6 | T | 22-09-2020 | IPR001611 | Leucine-rich repeat |
| UnnamedSample_HQ_transcript/9409|m.3642 | UnnamedSample_HQ_transcript/9409 | Coverage 0.491 too low. | 378dcdd68ccff9258ea43e2d879db7e8 | 1248 | Pfam | PF13855 | Leucine rich repeat | 127 | 185 | 1.2E-8 | T | 22-09-2020 | IPR001611 | Leucine-rich repeat |
| UnnamedSample_HQ_transcript/9409|m.3642 | UnnamedSample_HQ_transcript/9409 | Coverage 0.491 too low. | 378dcdd68ccff9258ea43e2d879db7e8 | 1248 | Pfam | PF00626 | Gelsolin repeat | 636 | 695 | 2.9E-5 | T | 22-09-2020 | IPR007123 | Gelsolin-like domain |
| UnnamedSample_HQ_transcript/9409|m.3642 | UnnamedSample_HQ_transcript/9409 | Coverage 0.491 too low. | 378dcdd68ccff9258ea43e2d879db7e8 | 1248 | Pfam | PF00626 | Gelsolin repeat | 758 | 824 | 7.2E-10 | T | 22-09-2020 | IPR007123 | Gelsolin-like domain |
| UnnamedSample_HQ_transcript/9409|m.3642 | UnnamedSample_HQ_transcript/9409 | Coverage 0.491 too low. | 378dcdd68ccff9258ea43e2d879db7e8 | 1248 | Pfam | PF00626 | Gelsolin repeat | 515 | 592 | 8.1E-14 | T | 22-09-2020 | IPR007123 | Gelsolin-like domain |
| UnnamedSample_HQ_transcript/9409|m.3642 | UnnamedSample_HQ_transcript/9409 | Coverage 0.491 too low. | 378dcdd68ccff9258ea43e2d879db7e8 | 1248 | Pfam | PF00626 | Gelsolin repeat | 1158 | 1232 | 2.5E-11 | T | 22-09-2020 | IPR007123 | Gelsolin-like domain |
| UnnamedSample_HQ_transcript/9409|m.3642 | UnnamedSample_HQ_transcript/9409 | Coverage 0.491 too low. | 378dcdd68ccff9258ea43e2d879db7e8 | 1248 | Pfam | PF00626 | Gelsolin repeat | 1045 | 1122 | 1.3E-4 | T | 22-09-2020 | IPR007123 | Gelsolin-like domain |
| UnnamedSample_HQ_transcript/13436|m.4935 | UnnamedSample_HQ_transcript/13436 | Coverage 0.988 too low. | 0b701c404293f2b97953dc5eda8878d8 | 377 | Pfam | PF00069 | Protein kinase domain | 71 | 329 | 9.2E-61 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/74422|m.18728 | UnnamedSample_HQ_transcript/74422 | Coverage 0.896 too low. | 90683e6d0e2456c72b54b6c1443a7b0a | 523 | Pfam | PF00004 | ATPase family associated with various cellular activities (AAA) | 39 | 179 | 4.8E-40 | T | 22-09-2020 | IPR003959 | ATPase, AAA-type, core |
| UnnamedSample_HQ_transcript/74422|m.18728 | UnnamedSample_HQ_transcript/74422 | Coverage 0.896 too low. | 90683e6d0e2456c72b54b6c1443a7b0a | 523 | Pfam | PF00004 | ATPase family associated with various cellular activities (AAA) | 322 | 450 | 3.5E-12 | T | 22-09-2020 | IPR003959 | ATPase, AAA-type, core |
| UnnamedSample_HQ_transcript/74422|m.18728 | UnnamedSample_HQ_transcript/74422 | Coverage 0.896 too low. | 90683e6d0e2456c72b54b6c1443a7b0a | 523 | Pfam | PF17862 | AAA+ lid domain | 206 | 242 | 7.5E-10 | T | 22-09-2020 | IPR041569 | AAA ATPase, AAA+ lid domain |
| UnnamedSample_HQ_transcript/29238|m.9287 | UnnamedSample_HQ_transcript/29238 | Coverage 0.534 too low. | 90683e6d0e2456c72b54b6c1443a7b0a | 523 | Pfam | PF00004 | ATPase family associated with various cellular activities (AAA) | 39 | 179 | 4.8E-40 | T | 22-09-2020 | IPR003959 | ATPase, AAA-type, core |
| UnnamedSample_HQ_transcript/29238|m.9287 | UnnamedSample_HQ_transcript/29238 | Coverage 0.534 too low. | 90683e6d0e2456c72b54b6c1443a7b0a | 523 | Pfam | PF00004 | ATPase family associated with various cellular activities (AAA) | 322 | 450 | 3.5E-12 | T | 22-09-2020 | IPR003959 | ATPase, AAA-type, core |
| UnnamedSample_HQ_transcript/29238|m.9287 | UnnamedSample_HQ_transcript/29238 | Coverage 0.534 too low. | 90683e6d0e2456c72b54b6c1443a7b0a | 523 | Pfam | PF17862 | AAA+ lid domain | 206 | 242 | 7.5E-10 | T | 22-09-2020 | IPR041569 | AAA ATPase, AAA+ lid domain |
| UnnamedSample_HQ_transcript/1208|m.726 | UnnamedSample_HQ_transcript/1208 | Coverage 0.649 too low. | ab0262b88d8802908726a484d1ba2e84 | 1852 | Pfam | PF00052 | Laminin B (Domain IV) | 874 | 1009 | 9.4E-23 | T | 22-09-2020 | IPR000034 | Laminin IV |
| UnnamedSample_HQ_transcript/1208|m.726 | UnnamedSample_HQ_transcript/1208 | Coverage 0.649 too low. | ab0262b88d8802908726a484d1ba2e84 | 1852 | Pfam | PF00053 | Laminin EGF domain | 1044 | 1091 | 6.5E-10 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/1208|m.726 | UnnamedSample_HQ_transcript/1208 | Coverage 0.649 too low. | ab0262b88d8802908726a484d1ba2e84 | 1852 | Pfam | PF00053 | Laminin EGF domain | 1252 | 1296 | 4.0E-8 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/1208|m.726 | UnnamedSample_HQ_transcript/1208 | Coverage 0.649 too low. | ab0262b88d8802908726a484d1ba2e84 | 1852 | Pfam | PF00053 | Laminin EGF domain | 38 | 70 | 4.7E-6 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/1208|m.726 | UnnamedSample_HQ_transcript/1208 | Coverage 0.649 too low. | ab0262b88d8802908726a484d1ba2e84 | 1852 | Pfam | PF00053 | Laminin EGF domain | 1205 | 1249 | 3.4E-5 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/1208|m.726 | UnnamedSample_HQ_transcript/1208 | Coverage 0.649 too low. | ab0262b88d8802908726a484d1ba2e84 | 1852 | Pfam | PF00053 | Laminin EGF domain | 3 | 35 | 1.9E-4 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
A
B
C
D
E
F
G
H
I
J
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
| 1. Protein accession (e.g. P51587) | |||||||||
| 2. Sequence MD5 digest (e.g. 14086411a2cdf1c4cba63020e1622579) | |||||||||
| 3. Sequence length (e.g. 3418) | |||||||||
| 4. Analysis (e.g. Pfam / PRINTS / Gene3D) | |||||||||
| 5. Signature accession (e.g. PF09103 / G3DSA:2.40.50.140) | |||||||||
| 6. Signature description (e.g. BRCA2 repeat profile) | |||||||||
| 7. Start location | |||||||||
| 8. Stop location | |||||||||
| 9. Score - is the e-value (or score) of the match reported by member database method (e.g. 3.1E-52) | |||||||||
| 10. Status - is the status of the match (T: true) | |||||||||
| 11. Date - is the date of the run | |||||||||
| 12. (InterPro annotations - accession (e.g. IPR002093) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
| 13. (InterPro annotations - description (e.g. BRCA2 repeat) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
